The May 2024 edition of the EPND e-newsletter is packed with project updates, including the latest news on our platform, partners, research studies and events.

• We celebrate a major milestone for EPND: a new, extended iteration of our Study Catalogue. Launched alongside the AD/PD conference in March, the extended Catalogue offers unparalleled insights into the European landscape of neurodegeneration cohorts.
• We share new EPND findings, recently published in the Nature Aging journal. our co-Coordinator, Pieter Jelle Visser, explains how biomarker analysis can reveal subtypes of Alzheimer's disease, highlighting the potential for improved, tailored treatments.
• We feature an interview with our biomarker workstream lead, Charlotte Teunissen. Charlotte leads the Neurochemistry Laboratory at Amsterdam UMC, generating biomarkers to improve biological diagnosis, therapy development, and monitoring of neurodegenerative disease progression.

Read the newsletter here: https://mailchi.mp/epnd/newslettermay2024